Skin Manifestations clinical trials
The registry lists 29 studies for Skin Manifestations across more than 10 countries. 5 are recruiting or about to start. 21 of them are mainly about Skin Manifestations (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-04. Counting its 15 narrower conditions too, such as Purpura, Thrombocytopenic, Idiopathic: 1,693 studies, 362 open.
Get an email when these change. Save the Skin Manifestations studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Galderma R&D (5) · Botanee Group Co., Ltd. (3) · Takeda (2) · Derming SRL (1) · Centre Hospitalier Universitaire Dijon (1) · Jinnah Postgraduate Medical Centre (1) · Assiut University (1) · Jamaica Hospital Medical Center (1)
What is being tested here
Drugs under test in Skin Manifestations studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Mezagitamab | 2 | 2 | 2 |
| Adapalene | 0 | 0 | 2 |
| Metronidazole | 0 | 0 | 2 |
| Azelaic acid | 0 | 0 | 2 |
| Collagen | 0 | 0 | 1 |
| Sertaconazole | 0 | 1 | 1 |
| Sovleplenib | 0 | 0 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
Who these studies take
Of the 3 Skin Manifestations studies recruiting now, 2 (67%) set no upper age limit and 0 (0%) stop at 75 or younger. 1 (33%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (33%) | 1 (33%) |
| 18 | 3 (100%) | 3 (100%) |
| 30 | 3 (100%) | 3 (100%) |
| 40 | 3 (100%) | 3 (100%) |
| 50 | 3 (100%) | 3 (100%) |
| 65 | 3 (100%) | 3 (100%) |
| 75 | 3 (100%) | 3 (100%) |
| 85 | 3 (100%) | 3 (100%) |
Across all 29 studies, recruiting or not: 55% stop at 75 or younger and 52% at 65; 14% take children; 31% are for women only and 0% for men only; 72% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Skin Manifestations studies take
Of 14 interventional studies with no phase under Skin Manifestations, half reached primary completion within 6 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Interventional, no phase | 6 mo2–17 · 14 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
Studies
Recruiting first, then most recently updated. Showing 29 of 29. search them.
- A Study of Mezagitamab in Adults With Chronic Primary Immune ThrombocytopeniaRecruitingNCT06722235Phase 318 countries
- A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune ThrombocytopeniaRecruitingNCT06948318Phase 315 countries
- Assessment of Chilbains Occuring During Covid-19 InfectionRecruitingNCT043441191 country
- A Clinical Study on Pre-operative Intervention With Products During Aesthetic MedicineNot yet recruitingNCT06891924Not applicable
- Mucocutaneous Manifestations in Patients With Chronic Kidney Disease inNewVally and Assuit;Hospital Based StudyNot yet recruitingNCT05819320
- New Regenerative Approach for Dermal Renovation (Karisma)CompletedNCT06152718Not applicable2 countries
- The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)WithdrawnNCT06291415Phase 15 countries
- Study to Evaluate the Safety and Effectiveness of GP0116Active, not recruitingNCT05987163Not applicable2 countries
- A 56-day Clinical Study on Facial Skin RejuvenationCompletedNCT06188338Not applicable1 country
- A 28-day Clinical Study on Facial Skin RejuvenationCompletedNCT06140628Not applicable1 country
- Screening for Chromosomal Microarrangements by CGH-array in Developmental Anomalies of the Skin Suggestive of Mosaicism.CompletedNCT01950975Not applicable1 country
- Omegia Softgel Clinical Research ProgramCompletedNCT05872178Not applicable1 country
- Facial Skin Clinical and Microbial Profiling From Oral Probiotic SupplementationCompletedNCT05597254Not applicable1 country
- Tolerability Comparison Between Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy SkinCompletedNCT01046565Phase 11 country
- Tolerability Comparison of Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy SkinCompletedNCT01046396Phase 11 country
- Split-Face Tolerability Comparison Between MetroGel® 1% Versus Finacea® 15% in Subjects With Healthy SkinCompletedNCT01139008Phase 41 country
- Split-face Tolerability Comparison Between MetroGel® 1% vs Finacea® 15% in Subjects With Healthy SkinCompletedNCT01139047Phase 41 country
- Placebo Controlled Efficacy Evaluation of the Hydrolyzed Collagen Peptide In Adult FemalesStatus unknownNCT05235997Not applicable1 country
- Cutaneous Manifestations of Coronavirus Disease 2019(COVID-19).CompletedNCT050946871 country
- A Specialized Amino Acid Mixture on Body Composition and Skin State in Overweight and Obese Class I Postmenopausal WomenCompletedNCT04701463Not applicable1 country
- Efficacy of Vinh Wellness Collagen on Skin HealthCompletedNCT04449159Not applicable1 country
- ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITPCompletedNCT019716842 countries
- Effectiveness, Safety, and Cost Efficacy of Water (H2O) as a Substitute for Sodium Bicarbonate (NaHCO3) Plus Solution in Neutralization of Chemical Peeling Using 35% Glycolic Acid SolutionCompletedNCT04154436Not applicable1 country
- The Skin Wrinkle Test: a Simple Clinical Test of Regional Block SuccessCompletedNCT03873896Not applicable1 country
- Aesthetic Performance of "Profhilo®" Injective Intradermal Treatment for the NeckCompletedNCT04002856Not applicable1 country
- Effect of Oral Collagen Tripeptide on Skin Moisture and Wrinkles in Adult WomenCompletedNCT03505684Not applicable1 country
- Standard TDS Irritation Study: Trained Skin Grader vs. Digital ImagingWithdrawnNCT02787356Not applicable
- Tolerability and Efficacy of Anti-Aging Treatment Regimen in Subjects With PhotodamageCompletedNCT02422836Not applicable
- Once a Day Topical Treatment for Athlete's Foot Fungus Inbetween the Toes in Males and FemalesStatus unknownNCT00856596Phase 31 country